# PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

> **NCT07538518** · — · NOT_YET_RECRUITING · sponsor: **Lorena Saelices** · enrollment: 25 (estimated)

## Conditions studied

- Amyloidogenic Transthyretin (ATTR) Amyloidosis
- Cardiac Amyloidosis

## Interventions

- **DRUG:** Evuzamitide

## Key facts

- **NCT ID:** NCT07538518
- **Lead sponsor:** Lorena Saelices
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-03-15
- **Final completion:** 2028-04-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07538518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07538518, "PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07538518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*